JP2024515629A5 - - Google Patents
Info
- Publication number
- JP2024515629A5 JP2024515629A5 JP2023562895A JP2023562895A JP2024515629A5 JP 2024515629 A5 JP2024515629 A5 JP 2024515629A5 JP 2023562895 A JP2023562895 A JP 2023562895A JP 2023562895 A JP2023562895 A JP 2023562895A JP 2024515629 A5 JP2024515629 A5 JP 2024515629A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- composition according
- transgene
- tumor suppressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174803P | 2021-04-14 | 2021-04-14 | |
| US63/174,803 | 2021-04-14 | ||
| PCT/US2022/024680 WO2022221447A1 (en) | 2021-04-14 | 2022-04-13 | Materials and methods for neurofibromin 2/merlin (nf2) gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515629A JP2024515629A (ja) | 2024-04-10 |
| JP2024515629A5 true JP2024515629A5 (https=) | 2025-04-22 |
Family
ID=83639721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562895A Pending JP2024515629A (ja) | 2021-04-14 | 2022-04-13 | ニューロフィブロミン２／マーリン（ｎｆ２）遺伝子療法のための材料及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240189453A1 (https=) |
| EP (1) | EP4323014A4 (https=) |
| JP (1) | JP2024515629A (https=) |
| AU (1) | AU2022257000A1 (https=) |
| CA (1) | CA3216712A1 (https=) |
| WO (1) | WO2022221447A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5707863A (en) * | 1993-02-25 | 1998-01-13 | General Hospital Corporation | Tumor suppressor gene merlin |
| US5578462A (en) * | 1994-01-10 | 1996-11-26 | Bristol-Myers Squibb Company | NF2 isoforms |
| RU2432158C1 (ru) * | 2010-07-28 | 2011-10-27 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Профилактический бактерицидный лак для обработки ногтей |
| US20130137753A1 (en) * | 2010-08-03 | 2013-05-30 | University Of South Alabama | Methods and compositions for the diagnosis and treatment of breast cancer |
| WO2015171270A1 (en) * | 2014-05-06 | 2015-11-12 | Felder Mitchell S | Method for the treatment of neurofibromatosis |
| SG10201913266UA (en) * | 2015-12-11 | 2020-02-27 | Massachusetts Eye & Ear Infirmary | Materials and methods for delivering nucleic acids to cochlear and vestibular cells |
| JP2024520815A (ja) * | 2021-06-08 | 2024-05-24 | エヌエフ２ セラピューティクス， インコーポレイテッド | 神経線維腫性障害を処置するための組成物および方法 |
-
2022
- 2022-04-13 CA CA3216712A patent/CA3216712A1/en active Pending
- 2022-04-13 EP EP22788880.7A patent/EP4323014A4/en active Pending
- 2022-04-13 US US18/286,923 patent/US20240189453A1/en active Pending
- 2022-04-13 WO PCT/US2022/024680 patent/WO2022221447A1/en not_active Ceased
- 2022-04-13 JP JP2023562895A patent/JP2024515629A/ja active Pending
- 2022-04-13 AU AU2022257000A patent/AU2022257000A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022508182A5 (https=) | ||
| AU2026202070A1 (en) | Modified AAV capsid polypeptides for treatment of muscular diseases | |
| Tal | Adeno-associated virus-based vectors in gene therapy | |
| IL278213B1 (en) | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) | |
| JP2020533959A5 (https=) | ||
| RU2014137450A (ru) | Композиции вектора aav и способы переноса генов в клетки, органы и ткани | |
| US12359219B2 (en) | Transgene cassettes designed to express a human MECP2 gene | |
| JP2024099770A5 (https=) | ||
| JP2020054367A (ja) | 改変ｇ６ｐｃをコードするアデノ随伴ウイルスベクターおよびその使用 | |
| JP2022525302A5 (https=) | ||
| JP2023515072A5 (https=) | ||
| JP2022524434A5 (https=) | ||
| JP2017529395A5 (https=) | ||
| JP2020519629A5 (https=) | ||
| JP2021508241A5 (https=) | ||
| US20240269161A1 (en) | Methods and compositions for tau reduction gene therapy | |
| JP2023537358A5 (https=) | ||
| CN120380153A (zh) | 用于中枢神经系统中的基因表达的核酸调控元件以及使用方法 | |
| JP2023059858A5 (https=) | ||
| JP2021520811A5 (https=) | ||
| CN114144518A (zh) | 用于基因疗法的双亮氨酸拉链激酶抑制剂 | |
| WO2021211700A1 (en) | Compositions and methods for treatment of neurological disorders | |
| JP2024543253A5 (https=) | ||
| JP7641911B2 (ja) | 新型の酵素組成物 | |
| JP2024515629A5 (https=) |